Diminished inhibitory effect of noradrenaline on insulin release from mouse islets transplanted to kidney

Acta Diabetol. 1995 Jun;32(2):116-20. doi: 10.1007/BF00569569.

Abstract

Insulin release is inhibited by adrenergic alpha-2 agonism in normal beta-cells. To test whether the inhibitory response to noradrenaline is modified by transplantation, we studied insulin release from freshly isolated islets and from syngeneic islets transplanted under the kidney capsule of non-diabetic C57BL/6 mice. When perifused in vitro, fresh islets, as well as grafts harvested 1 or 3 weeks after transplantation, reacted to 2.5 mumol/l noradrenaline with a complete inhibition of insulin release induced by 16.7 mmol/l D-glucose. In contrast, islet grafts harvested after 6, 12, or 21 weeks exhibited a conspicuous insulin secretory response to 16.7 mmol/l glucose in the presence of 2.5 mumol/l noradrenaline. Also a concentration of 0.25 mumol/l, noradrenaline inhibited the glucose-induced insulin release from fresh islets but not from 6-week-old islet grafts. It is concluded that transplantation under the kidney capsule induces a decreased inhibitory responsiveness to noradrenaline in islet grafts.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-2 Receptor Antagonists
  • Adrenergic alpha-Agonists / pharmacology*
  • Animals
  • Graft Survival
  • In Vitro Techniques
  • Insulin / metabolism*
  • Insulin Antagonists / pharmacology*
  • Insulin Secretion
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism*
  • Islets of Langerhans Transplantation / physiology*
  • Kidney
  • Kinetics
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Norepinephrine / pharmacology*
  • Probability
  • Time Factors
  • Transplantation, Heterotopic

Substances

  • Adrenergic alpha-2 Receptor Antagonists
  • Adrenergic alpha-Agonists
  • Insulin
  • Insulin Antagonists
  • Norepinephrine